Zusammenfassung
Die Tatsache, daß der Infarkt fast ausschließlich durch den thrombotischen Verschluß eines Koronargefäßes meist auf dem Boden eines rupturierten Plaques entsteht [2] und daß die Dauer der Myokardischämie neben der Lokalisation des Thrombus die Größe des Infarktareals und damit die Prognose des Kranken bedingt, bestimmt das therapeutische Vorgehen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bode C, Peter K, Kübler W, Katus HA (1994) Aggressive thrombolytische Therapie des Myokardinfarktes - Grenzen und Möglichkeiten. Z Kardiol 83: 393–403
De Wood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial in-farction. N Engl J Med 303: 897–902
Furberg CD, Psaty BM, Meyer JV (1995) Nifedipine: Dose-related increase in mortality in patients with coronary heart disease. Circulation 92: 1326–1331
Gibson RS, Boden WE, Theroux P et al. (1986) Diltiazem and reinfarction in patients with non-Q-wave infarction: Results of a double-blind, randomized multicenter trial. N Engl. Med 315: 423–429
GREAT-Group (1992) Feasibility, safety and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. BMJ 305:548- 553
Gruppo Italiano Per Lo Studio Delia Streptochinasi NelPInfarto Miocardio (GISSI-1) (1987) Longterm effects of intravenous thrombolysis in acute myocardial infarction: Final report of the GISSI Study. Lancet 2: 871–374
Gruppo Italiano per lo Studio della Soprawivenza nelPInfarto Miocardio (GISSI-3) (1994) Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 343: 1115–1122
GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329: 673–692
GUSTO II a - Investigators (1994) Randomized Trial of Intravenous Heparin versus Recombinant Hirudin for acute coronary syndromes. Circulation 90: 1631
ISIS-1 Collaborative Group (1986) Randomized trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction. Lancet 2: 57–66
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomized trial of intravenous streptokinase, oral aspirin both or neither among 17187 cases of suspected myocardial infarction. Lancet 2: 349–360
ISIS-4 Collaborative Group (1995) A randomized factorial trial assessing oral captopril, oral mononitrate and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 345: 669–685
Kennedy JW (1995) Optimal management of acute myocardial infarction requires early and complete reperfusion. Circulation 91: 1905–1907
Late Study Group (1993) Late assessment of thrombolytic efficacy (LATE) study with alte- plase 6–24 h after onset of acute myocardial infarction. Lancet 342: 759–766
Latini R, Maggioni A, Flather M, Sleight P, Tognoni G (1995) ACE Inhibitor Use in Patients with Myocardial Infarction. Summary of Evidence from Clinical Trials. Circulation 92: 3132–3137
Neuhaus KL, Tebbe U, Gottwik M et al. (1988) Intravenous recombinant tissue-plasminogen- activator (rTPA) and urokinase in acute myocardial infarction. Results of the German activator urokinase study ( GAUS ). J Am Coll Cardiol 12: 581–587
Reeder GS, Gersh BJ (1993) Modern management of acute myocardial infarction. Curr Probl Cardiol: 87–155
Rustige J, Burczyk U, Werner A, Senges J (1990) Akuter Herzinfarkt. Verkiirzung der Pra- hospitalphase durch Massenaufklarung moglich. Dtsch Arztebl 18: 1450–1454
Smalling RW et al. (1995) More rapid, complete and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. Circulation 91: 2725–2732
The European Myocardial Infarction Project (1993) Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 329: 383–389
Woods KL, Fletcher S, Roffe C, Haider Y (1992) Intravenous magnesium sulphate in sus-pected acute myocardial infarction: results of the second Leicester intravenous magnesium intervention trial (LIMIT 2). Lancet 339: 1553–1558
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dietz, A. (1998). Medikamentöse Therapie des Herzinfarkts. In: Unger, F. (eds) Herzerkrankungen und Interventions-möglichkeiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80404-5_32
Download citation
DOI: https://doi.org/10.1007/978-3-642-80404-5_32
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80405-2
Online ISBN: 978-3-642-80404-5
eBook Packages: Springer Book Archive